Search for: "ACTAVIS"
Results 621 - 640
of 1,012
Sorted by Relevance
|
Sort by Date
21 Apr 2011, 11:14 pm
Generic manufacturers like Pliva Inc. and Actavis Inc. who make generic Reglan (including the pills that DeMahy used) may end up being responsible for not updating their warning labels to include information that the brand name manufacturers include in theirs even though federal laws didn’t let them include the warnings. [read post]
23 Feb 2015, 2:55 am
Never too late 32 [week ending Sunday 8 February] –- Brazilian PTO’s delays | The Research Handbook on International Intellectual Property reviewed | Laura Smith-Hewitt | IP, women and leadership: the poll responses | Decline of West’s trust in innovation | Wikipedia public domain photos |CJEU in Case C-383/12 P Environmental Manufacturing LLP v OHIM | The Nordic IP Forum | The future of EPO’s BoA | Warner-Lambert v… [read post]
11 Dec 2018, 4:55 am
Rose writes that, in short, the Court dismissed Warner-Lambert's appeal that the patent was sufficiently disclosed, and upheld Actavis and Mylan's appeal that the disputed claims were not even partially sufficient. [read post]
26 Jan 2015, 4:03 am
.* No pain for Actavis: Warner-Lambert fail to stop launch of generic pregabalinSecond medical use claims, skinny labels, and public policy issues around healthcare are the topics addressed in Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others [2015] EWHC 72 (Pat) (21 January 2015), a decision that Mr Justice Arnold has just delivered and on which Darren timely comments in this post.* BREAKING NEWS: CJEU says exhaustion only applies to the tangible medium of… [read post]
7 Apr 2013, 7:26 pm
He described the circuit split leading to FTC v Actavis currently pending in the United States Supreme Court. [read post]
20 Jul 2023, 3:44 am
BMS appealed the decision on several grounds (para. 89), mostly relating to whether the High Court had appropriately applied the law on plausibility as established by the UK Supreme Court in Warner-Lambert v Actavis [2018] UKSC 56. [read post]
8 Mar 2021, 1:17 am
This principle was considered by the UK Supreme Court in Warner Lambert v Actavis [2018] UKSC 56 (IPKat). [read post]
22 Nov 2017, 3:14 am
Guest Kat Eibhlin answers the question by analyzing the recent decision Generics (U.K) v Yeda, a practical application of the Supreme Court’s Actavis v Eli Lilly.Internet and Digital Media Law conference returns to London! [read post]
6 Apr 2015, 7:31 am
| Oprah Winfrey and OWN YOUR POWER trade mark | EPO December Administrative Council Meeting | Blurred Lines | Again on Actavis v Boehringer | Is the EU Patent Package diminishing the EU’s powers? [read post]
13 Dec 2021, 12:49 am
The most recent decisions we have from the CJEU on Article 3(c) are Actavis I (C-443/12) and Actavis II (C-577/13) (IPKat). [read post]
7 Jan 2019, 9:19 am
| The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling" | No pain, no gain: Plausibility in Warner-Lambert v Actavis | Testing the boundaries of subjectivity: Infringement of Swiss-type claims in Warner-Lambert v Actavis | Is SPINNING generic? [read post]
30 Sep 2014, 9:30 am
This time, according to a story in the New York Times, the manufacturer is Forest Laboratories (owned by Actavis), and the drug is Namenda, which is prescribed for Alzheimer’s patients. [read post]
29 Aug 2016, 11:03 am
| Judgement in Actavis v ICOS | Collective management of copyright for images displayed by search engines | Corporates and #Rio2016 | Global brandingNever too late 108 [week ending on Sunday 10 August] Limerick Competition - the results | UK finally speaks out about the "facts" of IP post Brexit| Is "Deadwood really cluttering up trade mark registers? [read post]
29 Feb 2016, 11:27 pm
. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A comprehensive explanation of trademarks | Actavis v Lilly.Never too late… [read post]
17 May 2018, 1:36 pm
Having presided over major decisions impacting both on IP law and practice, not the least Actavis v Eli Lilly, Baron Neuberger will be sharing his insights and reflections on “IP in the UK and Europe – a view from the top”. [read post]
19 Apr 2015, 4:01 pm
This year's version, subtitled "Maximising pharmaceutical patent lifecycles to foster innovation and growth", takes place at The Hotel Excelsior, Munich, from 22 to 23 June and is followed by a Masterclass on 24 June on how to draft solid pharma patent claims in light of the CJEU's rulings in Neurim, Medeva, Georgetown, Eli Lilly and Actavis v Sanofi. [read post]
14 May 2018, 12:30 pm
Birss would not be drawn on his views of the Supreme Court's decision in Eli Lilly v Actavis (see the IPKat here - the 109 comments on the post is a good indication of how controversial this decision has been). [read post]
4 Jan 2016, 7:28 am
**********PREVIOUSLY, ON NEVER TOO LATENever too late 78 [week ending on Sunday 27 December] – Zer-sum claim and lookalike products | 2015 Copyright Awards | Santa Claus and Section 52 | Jani writes on Dallas Buyers Club LLC v iiNet Limited | IP Hairballs | Actavis v Eli Lilly | Power outage at USPTO | Santa's GC resigns | Pet rock and IP.Never too late 77 [week ending on Sunday 20 December] – GC… [read post]
11 Jan 2016, 1:34 am
Never too late 78 [week ending on Sunday 27 December] – Zer-sum claim and lookalike products | 2015 Copyright Awards | Santa Claus and Section 52 | Jani writes on Dallas Buyers Club LLC v iiNet Limited | IP Hairballs | Actavis v Eli Lilly | Power outage at USPTO | Santa's GC resigns | Pet rock and IP.Never too late 77 [week ending on Sunday 20 December] – GC on 5-stripe shoe mark | EPO BoA… [read post]
26 Jun 2015, 4:10 am
PatLit features a guest post from Richard Kempner, Brian Whitehead and Stuart Jackson on the brace of recent Court of Appeals patent decisions (ConvaTec and Actavis v Lilly) which are currently preoccupying those good souls who spend their lives seeking to extract meaning from patent claims and descriptions. [read post]
